금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Polish Zloty: Dovish NBP tone risks downside – ING
ING economists Rafal Benecki and Adam Antoniak argue that reduced prospects of further tightening by...
Euro holds steady as traders assess Fed and ECB interest rate paths
EUR/USD trades in a narrow range on Tuesday as traders await greater clarity on the Federal Reserve'...
Buckle GAAP EPS of $0.92 beats by $0.18, revenue of $288.7M misses by $0.52M
Bank of America strategists see a different historical parallel for the AI rally — and it isn’t the dot-com boom
Bank of America strategists are negative on European equities as they weigh the boom-and-bust dynamics of the AI build-out
Inflation remains primary concern, KC Fed's Schmid says
WTI Oil hits fresh one-month lows below $86.50 amid US-Iran truce extension
Crude prices trend lower for the third day in a row on Friday, with the US benchmark West Texas Intermediate (WTI) barrel trading around $86.50 at the time of writing after hitting one-month lows a fe ...
UPS launches heavy air freight to Mexico as part of logistics investment
Euro: ECB hikes priced as Dollar softens – DBS
DBS strategist Philip Wee notes markets have strong expectations that the European Central Bank will hike at its next meeting, even as the Federal Reserve (Fed) debates internal reforms.
Laurentian Bank of Canada reports Q2 results
Dell and 6 More Stocks That Explain the Market Today
The PC and server maker’s stellar first-quarter earnings lift Hewlett Packard, IBM, and Super Micro Computer.
Fed: June meeting tests new chair – DBS
Philip Wee of DBS Group Research highlights that US Treasury yields have eased as PCE inflation moderates, but headline inflation remains elevated, keeping real Fed Funds Rates in focus.
Canadian Dollar: Rate gap and USMCA risks cap Loonie – ING
ING’s Francesco Pesole notes that the Canadian Dollar remains a G10 laggard despite a pause, with short‑term rate differentials and global equities driving USD/CAD.
Is CRISPR Therapeutics (CRSP) One Of The Under-The-Radar Stocks With Massive Upside For 2026?
With an analyst consensus upside of 52.3%, CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the under-the-radar stocks with massive upside for 2026. As CASGEVY reinforced confidence in the company’s l ...
Mattel Studios is ready for its close-up with investors